MRLN(MRLN)
MRLN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $22M | $46M | — |
| Low | $19M | $41M | — |
| High | $24M | $50M | — |
| EBITDA Avg | $-7M | $-15M | — |
| Low | $-8M | $-17M | — |
| High | $-6M | $-14M | — |
| EBIT Avg | $-7M | $-15M | — |
| Low | $-8M | $-17M | — |
| High | $-6M | $-14M | — |
| Net Income Avg | $-41M | $-24M | — |
| Low | $-47M | $-25M | — |
| High | $-36M | $-24M | — |
| EPS Avg | $-1.22 | $-0.72 | — |
| Low | $-1.39 | $-0.73 | — |
| High | $-1.05 | $-0.71 | — |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 2 | — / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $7M | $9M | $8M | $10M | $13M | $14M |
| Low | $5M | $7M | $7M | $8M | $11M | $12M |
| High | $8M | $10M | $10M | $12M | $15M | $17M |
| EBITDA Avg | $-2M | $-3M | $-3M | $-3M | $-4M | $-5M |
| Low | $-3M | $-3M | $-3M | $-4M | $-5M | $-6M |
| High | $-2M | $-2M | $-2M | $-3M | $-4M | $-4M |
| EBIT Avg | $-2M | $-3M | $-3M | $-3M | $-4M | $-5M |
| Low | $-3M | $-3M | $-3M | $-4M | $-5M | $-6M |
| High | $-2M | $-2M | $-2M | $-3M | $-4M | $-4M |
| Net Income Avg | $-12M | $-14M | $-14M | $-13M | $-13M | $-13M |
| Low | $-15M | $-17M | $-17M | $-16M | $-16M | $-16M |
| High | $-9M | $-11M | $-11M | $-10M | $-10M | $-10M |
| EPS Avg | $-0.17 | $-0.20 | $-0.19 | $-0.18 | $-0.17 | $-0.17 |
| Low | $-0.21 | $-0.24 | $-0.23 | $-0.22 | $-0.22 | $-0.22 |
| High | $-0.13 | $-0.15 | $-0.15 | $-0.14 | $-0.13 | $-0.13 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |